Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Saeed Dabestani, Christian Beisland, Grant D. Stewart, Karim Bensalah, Eirikur Gudmundsson, Thomas B. Lam, William Gietzmann, Paimaun Zakikhani, Lorenzo Marconi, Sergio Fernandéz-Pello, Serenella Monagas, Samuel P. Williams, Thomas Powles, Erik Van Werkhoven, Richard Meijer, Alessandro Volpe, Michael Staehler, Börje Ljungberg & Axel Bex. (2019) Increased use of cross-sectional imaging for follow-up does not improve post-recurrence survival of surgically treated initially localized R.C.C.: results from a European multicenter database (R.E.C.U.R.). Scandinavian Journal of Urology 53:1, pages 14-20.
Read now
Read now
Articles from other publishers (18)
Juliet A. Usher‐Smith, Lanxin Li, Lydia Roberts, Hannah Harrison, Sabrina H. Rossi, Stephen J. Sharp, Carol Coupland, Julia Hippisley‐Cox, Simon J. Griffin, Tobias Klatte & Grant D. Stewart. (2022) Risk models for recurrence and survival after kidney cancer: a systematic review. BJU International 130:5, pages 562-579.
Crossref
Crossref
Philipp Strauss, Mariell Rivedal, Andreas Scherer, Øystein Eikrem, Sigrid Nakken, Christian Beisland, Leif Bostad, Arnar Flatberg, Eleni Skandalou, Vidar Beisvåg, Jessica Furriol & Hans-Peter Marti. (2022) A multiomics disease progression signature of low-risk ccRCC. Scientific Reports 12:1.
Crossref
Crossref
Chenghao Zhanghuang, Jinkui Wang, Zhaoxia Zhang, Liming Jin, Xiaojun Tan, Tao Mi, Jiayan Liu, Mujie Li & Dawei He. (2022) A Web-Based Prediction Model for Cancer-Specific Survival of Elderly Patients With Clear Cell Renal Cell Carcinoma: A Population-Based Study. Frontiers in Public Health 9.
Crossref
Crossref
Haijie Zhang, Fu Yin, Menglin Chen, Liyang Yang, Anqi Qi, Weiwei Cui, Shanshan Yang & Ge Wen. (2022) Development and Validation of a CT-Based Radiomics Nomogram for Predicting Postoperative Progression-Free Survival in Stage I–III Renal Cell Carcinoma. Frontiers in Oncology 11.
Crossref
Crossref
Sigrid Nakken, Øystein Eikrem, Hans-Peter Marti, Christian Beisland, Leif Bostad, Andreas Scherer, Arnar Flatberg, Vidar Beisvag, Eleni Skandalou, Jessica Furriol & Philipp Strauss. (2021) AGAP2-AS1 as a prognostic biomarker in low-risk clear cell renal cell carcinoma patients with progressing disease. Cancer Cell International 21:1.
Crossref
Crossref
Kalle E. Mattila, Teemu D. Laajala, Sara V. Tornberg, Tuomas P. Kilpeläinen, Paula Vainio, Otto Ettala, Peter J. Boström, Harry Nisen, Laura L. Elo & Panu M. Jaakkola. (2021) A three-feature prediction model for metastasis-free survival after surgery of localized clear cell renal cell carcinoma. Scientific Reports 11:1.
Crossref
Crossref
Gigja Gudbrandsdottir, Helene H. Aarstad, Leif Bostad, Karin M. Hjelle, Hans J. Aarstad, Øystein Bruserud, Tor Henrik Anderson Tvedt & Christian Beisland. (2020) Serum levels of the IL-6 family of cytokines predict prognosis in renal cell carcinoma (RCC). Cancer Immunology, Immunotherapy 70:1, pages 19-30.
Crossref
Crossref
Helene Hersvik Aarstad, Gigja Guðbrandsdottir, Karin M. Hjelle, Leif Bostad, Øystein Bruserud, Tor Henrik Anderson Tvedt & Christian Beisland. (2020) The Biological Context of C-Reactive Protein as a Prognostic Marker in Renal Cell Carcinoma: Studies on the Acute Phase Cytokine Profile. Cancers 12:7, pages 1961.
Crossref
Crossref
Naveen S. Vasudev, Michelle Hutchinson, Sebastian Trainor, Roisean Ferguson, Selina Bhattarai, Adebanji Adeyoju, Jon Cartledge, Michael Kimuli, Shibendra Datta, Damian Hanbury, David Hrouda, Grenville Oades, Poulam Patel, Naeem Soomro, Grant D. Stewart, Mark Sullivan, Jeff Webster, Michael Messenger, Peter J. Selby & Rosamonde E. Banks. (2020) UK Multicenter Prospective Evaluation of the Leibovich Score in Localized Renal Cell Carcinoma: Performance has Altered Over Time. Urology 136, pages 162-168.
Crossref
Crossref
Yanxiang Shao, Sanchao Xiong, Guangxi Sun, Weichao Dou, Xu Hu, Weixiao Yang, Thongher Lia, Shi Deng, Qiang Wei, Hao Zeng & Xiang Li. (2019) Prognostic analysis of postoperative clinically nonmetastatic renal cell carcinoma. Cancer Medicine 9:3, pages 959-970.
Crossref
Crossref
Amado J. Zurita. 2020. Kidney Cancer. Kidney Cancer
21
29
.
Saeed Dabestani, Christian Beisland, Grant D. Stewart, Karim Bensalah, Eirikur Gudmundsson, Thomas B. Lam, William Gietzmann, Paimaun Zakikhani, Lorenzo Marconi, Sergio Fernandéz-Pello, Serenella Monagas, Samuel P. Williams, Christian Torbrand, Thomas Powles, Erik Van Werkhoven, Richard Meijer, Alessandro Volpe, Michael Staehler, Börje Ljungberg & Axel Bex. (2019) Long-term Outcomes of Follow-up for Initially Localised Clear Cell Renal Cell Carcinoma: RECUR Database Analysis. European Urology Focus 5:5, pages 857-866.
Crossref
Crossref
Han Jie Lee, Alvin Lee, Hong Hong Huang & Weber Kam On Lau. (2019) External validation of the updated Leibovich prognostic models for clear cell and papillary renal cell carcinoma in an Asian population. Urologic Oncology: Seminars and Original Investigations 37:6, pages 356.e9-356.e18.
Crossref
Crossref
Pedro C. Barata & Brian I. Rini. (2017) Treatment of renal cell carcinoma: Current status and future directions. CA: A Cancer Journal for Clinicians 67:6, pages 507-524.
Crossref
Crossref
Zheng Liu, Yu Zhu, Yiwei Wang, Qiang Fu, Hangcheng Fu, Zewei Wang, Junyu Zhang, Gaoxiang Li, Jiejie Xu & Bo Dai. (2017) Prognostic value of granulocyte colony-stimulating factor in patients with non-metastatic clear cell renal cell carcinoma. Oncotarget 8:41, pages 69961-69971.
Crossref
Crossref
Haijian Zhang, Yidong Liu, Huyang Xie, Weisi Liu, Qiang Fu, Dengfu Yao, Jiejie Xu & Jianxin Gu. (2017) High mucin 5AC expression predicts adverse postoperative recurrence and survival of patients with clear-cell renal cell carcinoma. Oncotarget 8:35, pages 59777-59790.
Crossref
Crossref
Y. A. M. Kuijpers, R. P. Meijer, G. N. Jonges, J. de Jong, J. L. H. R. Bosch, S. Horenblas & A. Bex. (2016) Potentially curable recurrent disease after surgically managed non-metastatic renal cell carcinoma in low-, intermediate- and high-risk patients. World Journal of Urology 34:8, pages 1073-1079.
Crossref
Crossref
Christian Beisland, Gigja Guðbrandsdottir, Lars A. R. Reisæter, Leif Bostad & Karin M. Hjelle. (2016) A prospective risk-stratified follow-up programme for radically treated renal cell carcinoma patients: evaluation after eight years of clinical use. World Journal of Urology 34:8, pages 1087-1099.
Crossref
Crossref